2007 saw significant changes in patent law, and 2008 is promising additional significant developments. Those changes have significant effects on the value of patents and on how medical device developers and manufacturers should manage their patent strategy. The paper and discussion will detail those changes and provide practical guidance on what steps a medical device company can take to properly address those changes.
Volume Subject Area:
Clinical and Regulatory
This content is only available via PDF.
Copyright © 2008
by Whiteford, Taylor & Preston LLP
You do not currently have access to this content.